Novo completely oversold
Updated
🐂 Trade Idea: Long - NOVO
🔥 Account Risk: 20.00%
📈 Recommended Product: Stock
🔍 Entry: +/- 750.00
🐿 DCA: No
😫 Stop-Loss: 675.00
🎯 Take-Profit #1: 1,000.00 (50%)
🎯 Trail Rest: Yes
🚨🚨🚨 Important: Don’t forget to always wait for strong confirmation once possible entry zone is reached. Trade ideas don’t work all the time no matter how good they look. Do not get a victim of FOMO, there is always another trade idea waiting. 🚨🚨🚨
If you like what you see don’t forget to leave a comment 💬 or smash that like ❤️ button!
—
Novo Nordisk is completely oversold (in fear of RFK) and so is the rest of the Pharma sector as well. Nevertheless, Novo is still printing money and trial results for a new product should come in end 24 or beginning 25 for the oral version of the weight loss drug. The fear over political decisions in the US should be used to buy the Pharma sector. For me, it is Novo and Regeneron.
—
Disclaimer & Disclosures pursuant to §34b WpHG
The trades shown here related to stocks, cryptos, commodities, ETFs and funds are always subject to risks. All texts as well as the notes and information do not constitute investment advice or recommendations. They have been taken from publicly available sources to the best of our knowledge and belief. All information provided (all thoughts, forecasts, comments, hints, advice, stop loss, take profit, etc.) are for educational and private entertainment purposes only.
Nevertheless, no liability can be assumed for the correctness in each individual case. Should visitors to this site adopt the content provided as their own or follow any advice given, they act on their own responsibility.
🔥 Account Risk: 20.00%
📈 Recommended Product: Stock
🔍 Entry: +/- 750.00
🐿 DCA: No
😫 Stop-Loss: 675.00
🎯 Take-Profit #1: 1,000.00 (50%)
🎯 Trail Rest: Yes
🚨🚨🚨 Important: Don’t forget to always wait for strong confirmation once possible entry zone is reached. Trade ideas don’t work all the time no matter how good they look. Do not get a victim of FOMO, there is always another trade idea waiting. 🚨🚨🚨
If you like what you see don’t forget to leave a comment 💬 or smash that like ❤️ button!
—
Novo Nordisk is completely oversold (in fear of RFK) and so is the rest of the Pharma sector as well. Nevertheless, Novo is still printing money and trial results for a new product should come in end 24 or beginning 25 for the oral version of the weight loss drug. The fear over political decisions in the US should be used to buy the Pharma sector. For me, it is Novo and Regeneron.
—
Disclaimer & Disclosures pursuant to §34b WpHG
The trades shown here related to stocks, cryptos, commodities, ETFs and funds are always subject to risks. All texts as well as the notes and information do not constitute investment advice or recommendations. They have been taken from publicly available sources to the best of our knowledge and belief. All information provided (all thoughts, forecasts, comments, hints, advice, stop loss, take profit, etc.) are for educational and private entertainment purposes only.
Nevertheless, no liability can be assumed for the correctness in each individual case. Should visitors to this site adopt the content provided as their own or follow any advice given, they act on their own responsibility.
Trade active
The descending wedge broke to the upper side, and the trendline was defended. Looks good and bullish. I'd recommend checking out my REGN idea too.Trade closed: stop reached
Do not touch this stock now. There is a possibility it may bounce, but given the results from the ad hoc and the loss of trust, it's to risky. Novo did state his weight loss drug would at least reach 25% of weight loss but did only reach 22.X%, making Eli Lilly's product the better one. This can happen with bio tech stocks and makes trading them more risky than trading other stocks. 
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.